Senores Pharmaceuticals Ltd. IPO

Senores Pharmaceuticals IPO is a book-built issue worth Rs 582.11 crores, comprising a fresh issue of 1.28 crore shares aggregating to Rs 500.00 crores and an offer for sale of 0.21 crore shares worth Rs 82.11 crores. The IPO opens for subscription on December 20, 2024, and closes on December 24, 2024. Allotment is expected on December 26, 2024, with a tentative listing date of December 30, 2024, on BSE and NSE. The price band is Rs 372 to Rs 391 per share. Retail investors can apply for a minimum lot size of 38 shares, requiring Rs 14,858. sNII and bNII investments start at Rs 2,08,012 and Rs 10,10,344, respectively.

RHP
View
DRHP
View
Open Date

2024-12-20

Close Date

2024-12-24

Senores Pharmaceuticals Ltd. IPO Details

Check out the issue details for Senores Pharmaceuticals Ltd. IPO as disclosed in SEBI.

Price Band

₹ 372 - 391

Issue Size

582.11 Cr.

Issue Type

Book Built

Open

2024-12-20

Close

2024-12-24

Listing Date

2024-12-30

Company Financials

You can get the following financial statements of Senores Pharmaceuticals Ltd. as of now.

Senores Pharma IPO Details

The details about the Senores Pharma IPO are as follows:

  • The issue size of the IPO is 582.11 Cr.
  • The price band for Senores Pharma IPO is Rs 372 to Rs 391.
  • The shares of Senores Pharma IPO will list on 30th December 2024.
  • The latest tentative GMP of Senores Pharma IPO is Rs 191.
  • The shares of Senores Pharma IPO are subscribed 14.65 Times.

 

Senores Pharma IPO Valuation

The approx valuation of Senores Pharma IPO based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 391
Existing Shares (Qty) 3.32 Cr
Fresh Issue 500 Cr
Market Cap 1798.12 Cr
EPS (FY24) Rs 13.67
PE Ratio 28.60x
Industry PE 38.84x

 

Senores Pharma IPO Issue Size

Senores Pharma IPO issue size is 582.11 Cr.

Issue Amount
Fresh Issue 500 Cr
Offer For Sale 82.11 Cr

 

Senores Pharma IPO Market Lot

An individual can apply for a minimum of 1 lot of 38 shares and a maximum of 13 lots of 494 shares. Find the details below:

Application Lot Shares Amount
Minimum 1 38 Rs 14,858
Maximum 13 494 Rs 1,93,154

 

Senores Pharma IPO Share Offer

The shares of Senores Pharma IPO are subscribed 14.65 Times. The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Minimum 75%
Non-Institutional Maximum 15%
Retail Individual Maximum 10%

 

Senores Pharma IPO GMP (Grey Market Premium)

As on GMP (Tentative)
23 December 2024 Rs 191

Senores Pharma IPO GMP is purely for informational purposes. Invest in an IPO after thoroughly researching on your own.

Senores Pharma IPO Dates

Find below the dates for Senores Pharma IPO

Schedule Date
Basis of Allotment 26 December 2024
Refunds 27 December 2024
Credit to Demat Account 27 December 2024
IPO Listing Date 30 December 2024

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024
Net Sales 13.54 12.38 34.01
Total Expenditure 12.39 14.16 34.07
Operating Profit 1.16 -1.78 -0.06
Other Income 0.94 6.79 6.85
Interest 0.56 2.14 2.71
Depreciation 0.71 0.93 2.04
Exceptional Items 0 0 0
Profit Before Tax 0.83 1.94 2.04
Provision for Tax 0.15 0.74 1.22
Net Profit 0.68 1.2 0.81
Adjusted EPS (Rs.) 0.08 0.12 0.03

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 8.74 9.82 30.51
Total Reserves 24.95 29.11 137.61
Borrowings 12.22 24.17 19.88
Other N/C liabilities 0.01 1.66 7.02
Current liabilities 8.8 46.79 90.65
Total Liabilities 54.72 111.54 285.65
Assets
Net Block 1.59 7.77 24.09
Capital WIP 0 8.06 14.88
Intangible WIP 3.17 3.27 3.59
Investments 11.69 8.23 81.58
Loans & Advances 24.14 56.13 102.08
Other N/C Assets 0.14 0.4 19.48
Current Assets 13.98 27.68 39.96
Total Assets 54.72 111.54 285.65
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.83 1.94 2.04
Adjustment 0.6 -1.57 -2.59
Changes in Assets & Liabilities -25.35 -43.32 -61.07
Tax Paid -0.14 -0.47 -1.19
Operating Cash Flow -24.06 -43.41 -62.82
Investing Cash Flow -10.05 -5.23 -13.51
Financing Cash Flow 33.88 47.08 86.68
Net Cash Flow -0.23 -1.57 10.35
X